hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06264128 id: TheraPAP Comfort briefTitle: TPAP for Comfort in OSA overallStatus: RECRUITING date: 2024-03-08 date: 2024-05-31 date: 2024-06-30 date: 2024-02-16 date: 2024-03-18 name: SleepRes Inc. class: INDUSTRY briefSummary: TheraPAP is a prototype device (with full documented electrical and isolation safety) being developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control algorithm that lowers the pressure from the set pressure at the beginning of inspiration and does not return the pressure to the full set level until about halfway through expiration. The present study, TheraPAP Comfort, aims at assessing whether TPAP improves patient comfort vs. CPAP during supine wakefulness. conditions: Obstructive Sleep Apnea studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: All participants will undergo the same therapy combinations. CPAP (Continuous Positive Airway Pressure) and 2 level of TPAP (TheraPAP - novel CPAP approach pressure is reduced below therapy pressure from inspiration through mid exhalation specifically for comfort) will be assessed against each other in a round robin both backward and forward (6 total binary comparisons) for 2 levels of baseline pressure. primaryPurpose: TREATMENT masking: NONE maskingDescription: There is no specific intent to mask although participants will be naive to CPAP-type therapy, but they will be able to feel the difference. count: 80 type: ESTIMATED name: TPAP name: CPAP measure: CPAP v TPAP Patient Preference via Visual Analog Scale measure: TPAP 1 v TPAP 2 Patient Preference via Visual Analog Scale sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: SleepCenters of Middle Tennessee status: RECRUITING city: Murfreesboro state: Tennessee zip: 37129 country: United States name: Craig Salazar role: CONTACT phone: 615-893-4896 email: csalazar@sleepcenterinfo.com name: WIlliam H Noah, MD role: PRINCIPAL_INVESTIGATOR lat: 35.84562 lon: -86.39027 hasResults: False
nctId: NCT06264115 id: Soh-Med-24-01-05MS briefTitle: Outcomes of Three Ports Versus Four Ports Laparoscopic Cholecystectomy, Sohag General Surgery Department Experience overallStatus: ENROLLING_BY_INVITATION date: 2024-01-01 date: 2024-12-31 date: 2024-12-31 date: 2024-02-16 date: 2024-02-20 name: Sohag University class: OTHER briefSummary: To compare the outcomes of three ports and four ports Laparoscopic Cholecystectomy conditions: Cholecystitis, Chronic studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 50 type: ESTIMATED name: Laparoscopic Cholecystectomy measure: Postoperative pain score measure: Operative time measure: length of hospital stay measure: Total postoperative morphine consumption measure: Time of first analgesic sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Sohag university city: Sohag country: Egypt lat: 26.55695 lon: 31.69478 hasResults: False
nctId: NCT06264102 id: 2024/1/1 briefTitle: Influence of Dalcroze Eurhythmics on Pains in Older Women overallStatus: COMPLETED date: 2019-01-11 date: 2019-03-08 date: 2019-07-15 date: 2024-02-16 date: 2024-02-16 name: Poznan University of Physical Education class: OTHER briefSummary: In this study, we attempted to answer the question of whether participation in a 12-week rhythmic exercise program using the Dalcroze method affects the level of intensity of pain experienced by women over the age of 65. The level of pain was determined on a numerical scale from 1 to 10 and involved headaches, back pain and leg pain. conditions: Back Pain conditions: Headache conditions: Leg Pain studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 61 type: ACTUAL name: Physical exercise program measure: Pain levels before exercise program measure: Results of pain levels after exercise program sex: FEMALE minimumAge: 65 Years stdAges: OLDER_ADULT facility: Poznan University of Physical Education city: Poznań state: Wielkopolska zip: 61-871 country: Poland lat: 52.40692 lon: 16.92993 hasResults: False
nctId: NCT06264089 id: 202015 briefTitle: Effects of Preservation Rhinoplasty Nasal Valve Angle and Area overallStatus: COMPLETED date: 2020-08-06 date: 2023-08-30 date: 2023-08-30 date: 2024-02-16 date: 2024-02-16 name: Yuzuncu Yıl University class: OTHER briefSummary: The study planned to compare the internal nasal valve angle measurements of patients who underwent preservation rhinoplasty before and after surgery. conditions: Nasal Obstruction, Bilateral studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 100 type: ACTUAL name: Preservation Rhinoplasty Nasal Valve Angle and Area measure: Nasal Obstruction Symptom Evaluation Scale (NOSE) measure: Reformatted coronal Computed tomography sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Yaser Said Cetin city: Van zip: 65080 country: Turkey lat: 38.49457 lon: 43.38323 hasResults: False
nctId: NCT06264076 id: 686340 id: CIV-NO-23-09-043976 type: OTHER domain: Eudamed CIV ID briefTitle: Ligament Balancing in Total Knee Arthroplasty acronym: BLIS-TKA overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-12-31 date: 2025-12-31 date: 2024-02-16 date: 2024-02-16 name: Oslo University Hospital class: OTHER name: Vestre Viken Hospital Trust briefSummary: The goal of this interventional pilot study is to evaluate if performing ligament balancing on the medial collateral ligament (MCL) in a more systematical manner with a novel instrument can produce more objective and repeatable ligament lengthening in Total Knee Arthroplasty. The main questions it aim to answer are:
Participants must consent prior to the surgery, but inclusion is only done once ligament balancing is indicated during surgery. Patients will be follow-up as standard protocol for Total Knee Arthroplasty patients at the hospital. conditions: Ligament; Laxity, Knee conditions: Knee Osteoarthritis studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: Prospective, single-group, non-blind, interventional study primaryPurpose: TREATMENT masking: NONE maskingDescription: Non-blind count: 20 type: ESTIMATED name: A novel instrument for ligament balancing in total knee arthroplasty measure: Is it feasible to perform systematic ligament balancing on the MCL using a novel instrument? measure: MCL-lengthening in millimeters after ligament balancing using the novel instrument measure: Demographic information - height (cm) - and how this parameters affects ligament balancing. measure: Demographic information - weight (kg) - and how this parameters affects ligament balancing. measure: Demographic information - age (years) - and how this parameters affects ligament balancing. measure: Demographic information - sex (biologic, male/ female) - and how this parameters affects ligament balancing. measure: Demographic information - co-morbidities (disease state) - and how this parameters affect ligament balancing. measure: Patient reported outcome measures (PROM) using EQ-5D-5L measure: Patient reported outcome measures (PROM) using FJS-12 measure: Patient reported outcome measures (PROM) using KOOS-12 sex: ALL minimumAge: 40 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Baerum Hospital, Vestre Viken Hospital Trust city: Bærums Verk state: Viken zip: 1346 country: Norway name: Jarle Vik, MD role: CONTACT phone: 004793844926 email: jarle.vik@vestreviken.no lat: 59.94148 lon: 10.50273 facility: Oslo University Hospital, Ullevaal city: Oslo zip: 0450 country: Norway name: Lars HW Engseth, MD role: CONTACT phone: 004741254136 email: laengs@ous-hf.no lat: 59.91273 lon: 10.74609 hasResults: False
nctId: NCT06264063 id: D-DIST briefTitle: Study of Behavioral Dysfunctions and Related Neuronal Correlates in Patients With Dystonia acronym: D-DIST overallStatus: RECRUITING date: 2024-01-10 date: 2024-03-10 date: 2025-10-10 date: 2024-02-16 date: 2024-02-16 name: IRCCS Centro Neurolesi "Bonino-Pulejo" class: OTHER briefSummary: Dystonias represent hyperkinetic movement disorders characterized by protracted muscle contractions, such as to cause torsional movements and anomalous postures in different parts of the body. Although they occur more often in a focal form (blepharospasm, oromandibular dystonia, cervical dystonia, laryngeal dystonia, attitudinal cramps of the limbs) than segmental (involvement of several contiguous muscle groups, e.g. facial muscles and neck muscles), they are nevertheless capable of significantly influencing the quality of life, with consequent social and health costs. Although described as a predominantly motor disorder, the presence of non-motor symptoms in dystonias associated with alteration of the fronto-striatal circuits is increasingly recognized. Neuroimaging studies have highlighted that the striatum and, more specifically, striatal dopamine, is involved in high cognitive processes such as attention, reward-based learning and decision making. Clinical conditions associated with cortico-striatal circuit dysfunction and abnormal meso-striatal or meso-cortical dopamine transmission also appear to influence temporal estimation, delay discounting, showing an impulsive preference for immediate rewards over delayed gratification.
Based on these premises, the present project aims to evaluate the cognitive and affective aspects of dystonias, in line with neuroimaging research documenting structural and functional dysfunctions in the respective brain regions. conditions: Dystonia conditions: Neurologic Disorder conditions: NEUROSCIENCE studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SCREENING masking: SINGLE whoMasked: PARTICIPANT count: 102 type: ESTIMATED name: control group name: experimental group name: EEG power in alpha band measure: montreal cognitive assessment measure: Beck depression inventory measure: EEG power in alpha band sex: ALL minimumAge: 18 Years maximumAge: 60 Years stdAges: ADULT facility: IRCCS Centro Neurolesi Bonino Pulejo status: RECRUITING city: Messina zip: 98124 country: Italy name: Caterina Formica, PhD, PSY role: CONTACT phone: +3909060128185 email: katia.formica@irccsme.it lat: 38.19394 lon: 15.55256 hasResults: False
nctId: NCT06264050 id: 2023.04 briefTitle: Psychological Support Group and Its Effects on Mood, Anxiety and Coping acronym: SUPPORT overallStatus: ACTIVE_NOT_RECRUITING date: 2004-01-08 date: 2024-09-08 date: 2025-03-15 date: 2024-02-16 date: 2024-02-16 name: IRCCS San Camillo, Venezia, Italy class: OTHER briefSummary: The aim of this study is to verify the influence that participation in a Psychological Support Group has on anxiety, depression and coping skills in patients admitted to the IRCCS San Camillo Hospital.
The study consists of verifying whether the therapeutic activity of the Psychological Support Group (GSP) has an influence on the levels of anxiety, mood and coping skills in the patients who attend it. These purposes will be pursued through the administration to each patient at the beginning (pre) and at the end (post) of the period of attendance at the GSP, of validated scales: Stay Y2 (anxiety), BDI II(depressive symptoms), COPE NVD 25 (coping strategies) and the CORE-OM (outcomes of psychological activity). conditions: Coping Strategies conditions: Anxiety conditions: Nurse-Patient Relations conditions: Psychological conditions: Mood Depressed conditions: Rehabilitation conditions: Neurologic Manifestations studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: pre post study on a single cohort primaryPurpose: DIAGNOSTIC masking: NONE count: 19 type: ACTUAL name: evalutaion scales measure: The State-Trait Anxiety Inventory (STAI) Y2 measure: The Beck Depression Inventory II (BDI-II) measure: The Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) measure: The Coping Orientations to Problem Experienced NVI - 25 sex: ALL minimumAge: 18 Years maximumAge: 85 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06264037 id: 2023.03 id: Studio 1574 /IRCCS San Camillo type: OTHER domain: CESC di Venezia e IRCSS San Camillo briefTitle: The Experience in Neurorehabilitation Setting: a Qualitative Study acronym: NURSEXPERIENCE overallStatus: RECRUITING date: 2023-03-15 date: 2024-12-08 date: 2025-03-15 date: 2024-02-16 date: 2024-02-16 name: IRCCS San Camillo, Venezia, Italy class: OTHER briefSummary: In this exploratory qualitative study with a hermeneutic phenomenological approach, we will describe and understand the experience of treatment and hospitalization in hospitalized people suffering from stroke, multiple sclerosis, Parkinson\'s disease and patients post-neurosurgery for oncological causes. Patients will be interviewed in a semi-structured manner and sampling will take place for each of the pathology groups according to the saturation method. conditions: Rehabilitation conditions: Neurologic Disorder conditions: Stroke conditions: Parkinson Disease conditions: Multiple Sclerosis conditions: Neurosurgery studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 40 type: ESTIMATED name: semi structured interview measure: narrative contents sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Alberto Camuccio status: RECRUITING city: Venezia zip: 30126 country: Italy name: Alberto Camuccio, doctor role: CONTACT phone: +39412207516 email: alberto.camuccio@hsancamillo.it name: Enrico Dal Pozzo, doctor role: CONTACT phone: +39412207111 email: enrico.dalpozzo@hsancamillo.it lat: 45.43713 lon: 12.33265 facility: IRCCS San Camillo Department of Neurorehabilitation, Venezia status: RECRUITING city: Venezia zip: 30126 country: Italy name: Alberto Camuccio, doctor role: CONTACT phone: +39412207516 email: alberto.camuccio@hsancamillo.it name: Enrico Dal Pozzo, doctor role: CONTACT phone: +39412207111 email: enrico.dalpozzo@hsancamillo.it lat: 45.43713 lon: 12.33265 facility: IRCCS San Camillo Venezia status: RECRUITING city: Venezia zip: 30126 country: Italy name: Alberto Camuccio, doctor role: CONTACT phone: +39412207516 email: alberto.camuccio@hsancamillo.it name: Enrico Dal Pozzo, doctor role: CONTACT phone: +39412207111 email: enrico.dalpozzo@hsancamillo.it lat: 45.43713 lon: 12.33265 hasResults: False
nctId: NCT06264024 id: 519516 briefTitle: Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK) overallStatus: RECRUITING date: 2024-02-12 date: 2025-05-01 date: 2034-02-01 date: 2024-02-16 date: 2024-02-16 name: Oslo University Hospital class: OTHER briefSummary: The goal of this clinical trial is to compare CXL with combined treatment with CXL and t-PTK.
The main questions it aims to answer are whether combined treatment can give better visual acuity and if the treatments are equally safe. conditions: Keratoconus studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 81 type: ESTIMATED name: Corneal collagen cross linking (CXL) name: Transepithelial phototherapeutic keratectomy (t-PTK) measure: Visual acuity measure: Risk of progression measure: Visual acuity measure: Visual acuity measure: Visual acuity measure: Visual acuity measure: Visual acuity measure: Risk of progression measure: Risk of progression measure: Risk of progression measure: Risk of progression measure: Risk of progression measure: Depth of demarcation line (OCT) measure: Depth of demarcation line (confocal microscopy) measure: Patient reported outcome measure (PROMs) measure: Patient reported outcome measure (PROMs) measure: Patient reported outcome measure (PROMs) measure: Patient reported pain after surgery sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Department of Ophhtalmology, University of Oslo status: RECRUITING city: Oslo country: Norway name: Olav Kristianslund, MD, PhD role: CONTACT email: olakri@ous-hf.no name: Bjarne L Thorbjørnsen, MD role: CONTACT email: uxtbja@ous-hf.no lat: 59.91273 lon: 10.74609 hasResults: False
nctId: NCT06264011 id: 2023B0044 briefTitle: Discrimination and Religious Experiences of Adult Muslimahs in Salaat acronym: DREAMS overallStatus: RECRUITING date: 2023-07-13 date: 2024-06 date: 2024-06 date: 2024-02-16 date: 2024-04-26 name: Ohio State University class: OTHER briefSummary: This goal of this clinical trial is to examine the effects of the Muslim prayer (salaat) on physiological arousal among Muslim women. This study aims to measure EEG and HRV during the salaat performance among Muslim women. Using EEG as a measure of physiological relaxation, HRV will be utilized as a measure of stress experienced by Muslim women whose prayer have been understudied in research on the salaat. Thus, the main questions it aims to answer are 1) whether salaat performed by Muslim women influences physiological relaxation similar to what is seen by men, and 2) Evaluate health-related correlates of perceived discrimination among Muslim women.
nctId: NCT06263998 id: HUC1-394 briefTitle: Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops overallStatus: NOT_YET_RECRUITING date: 2024-06-03 date: 2025-11-28 date: 2026-01-30 date: 2024-02-16 date: 2024-02-16 name: Huons Co., Ltd. class: INDUSTRY briefSummary: The objective is to evaluate the safety, local tolerability, and pharmacokinetics of NCP112 eye drops through single and multiple dose-escalation ocular administrations in healthy adults. conditions: Xerophthalmia studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 60 type: ESTIMATED name: NCP112 name: NCP112 Placebo measure: Treatment-Emergent Adverse Events measure: Evaluation of pharmacokinetic profile measure: Evaluation of pharmacokinetic profile sex: ALL minimumAge: 19 Years maximumAge: 50 Years stdAges: ADULT hasResults: False
nctId: NCT06263985 id: 20214133 briefTitle: Axis(TM) Solvent-dehydrate Dermal Allograft in the Treatment of Pelvic Organ Prolapse. overallStatus: ACTIVE_NOT_RECRUITING date: 2021-11-02 date: 2025-05-30 date: 2025-05-30 date: 2024-02-16 date: 2024-02-16 name: Michigan Institution of Women's Health PC class: OTHER name: Coloplast A/S briefSummary: The goal of this study is to assess improvement in subjects who have undergone Axis Dermis, biologic mesh for pelvic organ prolapse repair. \[describe participant population/health conditions\]. The main question\[s\] it aims to answer are:
* Does subject notice a bulge Participants will undergo Axis Dermis pelvic organ prolapse repair procedure. conditions: Pelvic Organ Prolapse studyType: INTERVENTIONAL phases: PHASE4 allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: Subjects undergoing the treatment for pelvic organ prolapse with Axis Dermis biologic mesh. primaryPurpose: TREATMENT masking: NONE count: 50 type: ACTUAL name: Axis Dermis biologic mesh repair for pelvic organ prolapse measure: Improvement in function measure: Improvement in Anatomy measure: Assess complications or untoward side effects. sex: FEMALE minimumAge: 21 Years maximumAge: 89 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Advanced Urogynecology of Michigan city: Dearborn state: Michigan zip: 48124 country: United States lat: 42.32226 lon: -83.17631 hasResults: False
nctId: NCT06263972 id: 0168-21EMC briefTitle: Comparison of the Efficacy of Transcranial Direct Current Stimulation (tDCS) of the Primary Motor Cortex (M1) or the Prefrontal Cortex Combined With Aerobic Activity for Alleviation of Fibromyalgia Symptoms. overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2026-03 date: 2026-07 date: 2024-02-16 date: 2024-02-16 name: HaEmek Medical Center, Israel class: OTHER name: Technion, Israel Institute of Technology name: Rambam Health Care Campus briefSummary: The goal of this study is to demonstrate the effectiveness of treating fibromyalgia using combination of electrical stimulation with aerobic activity.
Participants will be randomly assigned to stimulation in a ratio of 1:1:1. 120 participants (40 in each group). The therapeutic course will include moderate aerobic physical activity (at 60% of the target heart rate adjusted for age) 3 times a week for 4 weeks (a week of adjustment, and 3 weeks of treatment), along with low current electrical stimulation for 3 weeks. conditions: Fibromyalgia conditions: Electric Shock studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 120 type: ESTIMATED name: Direct Stimulation Prefrontal Cortex name: Shame cortex stimulation name: Direct Stimulation to Motor Cortex name: erobic physical activity measure: Study objectives: • Comparing the effectiveness of direct electric current stimulation between the two stimulus areas Numeric pain rating scale. measure: Study objectives: • Comparing the effectiveness of direct electric current stimulation (tDCS) between the two stimulus areas and in relation Adult sensory profile test Raw score. measure: Study objectives: • Comparing the effectiveness of direct electric current stimulation between the two stimulus areas and in relation to The Montreal Cognitive Assessment (MoCA) score. measure: Study objectives: • Comparing the effectiveness of direct electric current stimulation between the two stimulus areas and in relation to Generalized Anxiety Disorder 7-Item Scale sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06263959 id: GST-HG131-II-01 briefTitle: A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B overallStatus: RECRUITING date: 2023-12-29 date: 2024-09-01 date: 2024-11-01 date: 2024-02-16 date: 2024-02-16 name: Fujian Akeylink Biotechnology Co., Ltd. class: INDUSTRY briefSummary: A randomized, double-blind, placebo-controlled Phase IIa clinical study to evaluate the safety and efficacy of GST-HG131 tablets in patients with chronic hepatitis B conditions: Chronic Hepatitis B studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR count: 45 type: ESTIMATED name: GST-HG131 name: Placebo to match GST-HG131 measure: Change from Baseline in HBsAg levels measure: Number of participants with adverse events (AEs), serious adverse events (SAEs), and withdrawals due to AEs sex: ALL minimumAge: 35 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: The Fifth Medical Center of Chinese PLA General Hospital status: RECRUITING city: Beijing country: China name: Tang Yanan role: CONTACT phone: +8613585734994 email: annie_tyn@163.com lat: 39.9075 lon: 116.39723 hasResults: False